Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Cancer

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejca.2016.11.007PMID 28027515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Organ Preservation Using Contact Radiotherapy for Early Rectal Cancer: Outcomes of Patients Treated at a Single Centre in the UK.

  2017cited by this paper
• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2017cited by this paper
• Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.

  2016cited by this paper
• Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial.

  2016cited by this paper
• ORGAN PRESERVATION FOR CLINICAL T2N0 DISTAL RECTAL CANCER USING NEOADJUVANT CHEMORADIOTHERAPY AND LOCAL EXCISION: RESULTS OF A MULTICENTER PHASE 2 STUDY

  2015cited by this paper
• Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

  2015cited by this paper
• Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.

  2015cited by this paper
• Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment

  2015cited by this paper
• High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.

  2015cited by this paper
• Report from a consensus meeting: response to chemoradiotherapy in rectal cancer – predictor of cure and a crucial new choice for the patient

  2014cited by this paper
• Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

  2014cited by this paper
• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy.

  2013cited by this paper
• Contact radiotherapy for elderly patients with early low rectal cancers.

  2013cited by this paper
• Radiation dose-response model for locally advanced rectal cancer after pre-operative chemoradiotherapy

  2013cited by this paper
• Survival Outcome of Local Excision versus Radical Resection of Colon or Rectal Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study

  2013cited by this paper
• Contact radiotherapy using a 50 kV X-ray system: Evaluation of relative dose distribution with the Monte Carlo code PENELOPE and comparison with measurements

  2012cited by this paper
• Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy

  2012cited by this paper
• Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

  2012cited by this paper
• Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered.

  2011cited by this paper
• Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.

  2011cited by this paper
• Renaissance of contact x-ray therapy for treating rectal cancer

  2011cited by this paper
• Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization

  2010cited by this paper
• Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.

  2008cited by this paper
• Is the Increasing Rate of Local Excision for Stage I Rectal Cancer in the United States Justified?: A Nationwide Cohort Study From the National Cancer Database

  2007cited by this paper
• Role of Radiotherapy With Surgery for T3 and Resectable T4 Rectal Cancer: Evidence From Randomized Trials

  2006cited by this paper
• Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.

  2004cited by this paper
• Risk factors for an adverse outcome in early invasive colorectal carcinoma.

  2004cited by this paper
• Radiotherapy alone in the curative treatment of rectal carcinoma.

  2003cited by this paper
• Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone.

  2002cited by this paper
• [Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0].

  2000cited by this paper
• Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer.

  1992cited by this paper
• Present status of radiation therapy in the conservative management of rectal cancer.

  1990cited by this paper
• Intracavitary irradiation of early rectal cancer for cure A series of 186 cases

  1975cited by this paper
• Clinical Investigation : Gastrointestinal Cancer Correlation in Rectal Cancer Between Clinical Tumor Response After Neoadjuvant Radiotherapy and Sphincter or Organ Preservation : 10-Year Results of the Lyon R 96-02 Randomized Trial

  year unknowncited by this paper

• Organ preservation in rectal cancer with contact x-ray brachytherapy (Papillon): a refined Swiss protocol to improve real-world feasibility

  2025cites this paper
• Contact X-ray brachytherapy in rectal cancer: A systematic review and meta-analysis.

  2025cites this paper
• Clinical Prediction Models for Contact X‐Ray Brachytherapy in Managing Rectal Cancers: A Scoping Review

  2025cites this paper
• Contact X-ray Brachytherapy (CXB) as a boost therapy after neoadjuvant (chemo)radiation in high-risk locally advanced rectal cancer.

  2024cites this paper
• High Rates of Organ Preservation in Rectal Cancer with Papillon Contact X-ray Radiotherapy: Results from a Swiss Cohort

  2024influential citation
• Low energy contact X‐ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales

  2024cites this paper
• Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC) for Non-Operative Management (NOM) for Rectal Adenocarcinoma: Systematic Review and Guidelines.

  2024cites this paper
• Organ and Function Preservation in Gastrointestinal Malignancies.

  2023cites this paper
• The safety and efficacy of total mesorectal excision (TME) surgery following dose‐escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750)

  2023influential citation
• High‐dose rate endorectal brachytherapy for rectal cancer: A state‐of‐the‐art review

  2023cites this paper
• Patient and multidisciplinary team perspectives on watch and wait in rectal cancer

  2023cites this paper
• Organ Preservation in MSS Rectal Cancer

  2023cites this paper
• Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis

  2023cites this paper
• Contact X-Ray Brachytherapy for Early Rectal Cancer: A Review of Outcomes From a Single UK Centre

  2022cites this paper
• The Role of Contact X-Ray Brachytherapy in Early Rectal Cancer – Who, when and How?

  2022cites this paper
• Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer

  2022cites this paper
• Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV

  2022cites this paper
• GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer

  2021cites this paper
• Local Excision of Rectal Cancer After Neoadjuvant Treatment

  2020cites this paper
• Efficacy of dose-escalated chemoradiation on complete tumour response in patients with locally advanced rectal cancer (RECTAL-BOOST); a phase 2 randomised controlled trial.

  2020cites this paper
• Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes.

  2020cites this paper
• Clinical audit of rectal cancer patient referrals for Papillon contact brachytherapy

  2019cites this paper
• A systematic review comparing radiation toxicity after various endorectal techniques.

  2019influential citation
• Combined management of perianal rhabdomyosarcoma with chemotherapy, radical surgery, and irradiation: A series of three consecutive children.

  2019cites this paper
• A cohort study of local excision followed by adjuvant therapy incorporating a contact X‐ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer

  2019cites this paper
• A systematic review and meta-analysis of pT2 rectal cancer spread and recurrence pattern: Implications for target design in radiation therapy for organ preservation.

  2019cites this paper
• Systematic Review of Intensity-Modulated Brachytherapy (IMBT): Static and Dynamic Techniques.

  2019cites this paper
• Colorectal Cancer in Older Adults: Surgical Issues

  2019cites this paper
• Image-Guided Adaptive Endorectal Brachytherapy in the Non-Operative Management of Patients with Rectal Cancer.

  2019cites this paper
• Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer

  2018cites this paper
• Minimally invasive contact X-ray brachytherapy as an alternative option in patients with rectal cancer not suitable for bespoke surgical resection

  2018cites this paper
• Re: Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery

  2018cites this paper
• Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.

  2018cites this paper
• Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer.

  2018cites this paper
• Optimal management of localized rectal cancer in older patients.

  2018cites this paper
• In Reply to Habr-Gama et al.

  2018cites this paper
• A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy.

  2017cites this paper
• OPERA and Phase III Trials for Testing the Hypothesis That Planned Organ Preservation is Feasible in Selected Rectal Cancers

  2017cites this paper
• Organ Preservation for Early Rectal Adenocarcinoma : The OPERA EuropeanTrial to Bring Robust Evidence

  2017influential citation
• Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?

  2017cites this paper
• Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.

  2017cites this paper
• Advances in organ preserving strategies in rectal cancer patients.

  2017cites this paper
• Personalized treatments for elderly patients affected by rectal cancer

  2017cites this paper